HHBT Stock Overview
HH Biotechnology Holdings Company engages in health and green industries.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
HH Biotechnology Holdings Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0003 |
| 52 Week High | US$0.0005 |
| 52 Week Low | US$0.0002 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | -99.95% |
| Change since IPO | -99.99% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| HHBT | US Real Estate | US Market | |
|---|---|---|---|
| 7D | 0% | 3.9% | 1.2% |
| 1Y | n/a | 14.6% | 24.9% |
Return vs Industry: Insufficient data to determine how HHBT performed against the US Real Estate industry.
Return vs Market: Insufficient data to determine how HHBT performed against the US Market.
Price Volatility
| HHBT volatility | |
|---|---|
| HHBT Average Weekly Movement | n/a |
| Real Estate Industry Average Movement | 6.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HHBT has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HHBT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | Sheng Jiang | www.greatchinaholdings.com |
HH Biotechnology Holdings Company engages in health and green industries. It focuses on planting and supplying macadamia nuts for use in foods, cooking oils, healthy products, toiletries, and cosmetics. The company was formerly known as Great China International Holdings, Inc. and changed its name to HH Biotechnology Holdings Company in August 2016.
HH Biotechnology Holdings Company Fundamentals Summary
| HHBT fundamental statistics | |
|---|---|
| Market cap | US$4.22k |
| Earnings (TTM) | US$2.88m |
| Revenue (TTM) | US$7.95m |
0.0x
P/E Ratio0.0x
P/S RatioIs HHBT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HHBT income statement (TTM) | |
|---|---|
| Revenue | US$7.95m |
| Cost of Revenue | US$5.18m |
| Gross Profit | US$2.77m |
| Other Expenses | -US$107.02k |
| Earnings | US$2.88m |
Last Reported Earnings
Sep 30, 2016
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did HHBT perform over the long term?
See historical performance and comparison